DRUG · Mapped RxNorm record
Bevacizumab
Normalized identity: bevacizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Bevacizumab vs Dacarbazine in Metastatic Melanoma
NCT01705392
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Propranolol
Normalized identity: propranololView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Enalapril
Normalized identity: enalaprilView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Dacarbazine
Normalized identity: dacarbazineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBevacizumab vs Dacarbazine in Metastatic Melanoma
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
BevacizumabDRUG · verified · RxNorm: bevacizumab
PropranololDRUG · verified · RxNorm: propranolol
EnalaprilDRUG · verified · RxNorm: enalapril
DacarbazineDRUG · verified · RxNorm: dacarbazine
Sponsors & collaborators
Haukeland University Hospitallead sponsor
The Norwegian Melanoma Groupcollaborator
Norwegian Cancer Societycollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01705392 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.